The bronchodilator effect of salbutamol administered by IPPB to patients with asthma. A controlled comparison with isoproterenol and placebo.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000605:Amino Alcohols / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000628:therapy; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use; D010919:Placebos; D011175:Positive-Pressure Respiration; D012129:Respiratory Function Tests; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D000605:Amino Alcohols; D002082:Butylamines; D010627:Phenethylamines; D010919:Placebos; D013566:Sympathomimetics; D007545:Isoproterenol